gallstones glp-1 FDA Data Link Diabetes Drug Class to Gallbladder Disease GLP-1s for Weight Loss: What

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may have a welcome benefit in addition to weight loss and glycemic control, with new data presented at ObesityWeek, the annual meeting of the Obesity Society, showing that use of these medications is associated with a reduction in problematic alcohol use

Neither medication has demonstrated confirmed thyroid cancer risk in controlled human studies

Common adverse reactions include nausea, vomiting, constipation, and diarrhea

Hence, more studies investigating cortical effects of different subtypes of GLP-1 on depression or anxiety at the whole brain level, with longer assessment periods, and complete neuropsychological evaluations or behavioral observations are still needed both for preclinical and clinical studies